nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—RXRA—systemic lupus erythematosus	0.376	1	CbGaD
Tretinoin—NR0B1—Dexamethasone—systemic lupus erythematosus	0.0761	0.207	CbGbCtD
Tretinoin—CYP2C18—Dapsone—systemic lupus erythematosus	0.0371	0.101	CbGbCtD
Tretinoin—CYP4A11—Dexamethasone—systemic lupus erythematosus	0.0366	0.0996	CbGbCtD
Tretinoin—CYP2A6—Prednisolone—systemic lupus erythematosus	0.0132	0.036	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Dapsone—systemic lupus erythematosus	0.0123	0.0335	CbGbCtD
Tretinoin—CYP3A7—Dapsone—systemic lupus erythematosus	0.0123	0.0335	CbGbCtD
Tretinoin—CYP3A5—Dapsone—systemic lupus erythematosus	0.00925	0.0252	CbGbCtD
Tretinoin—CYP2C8—Dapsone—systemic lupus erythematosus	0.00889	0.0242	CbGbCtD
Tretinoin—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0087	0.0237	CbGbCtD
Tretinoin—CYP3A7—Hydrocortisone—systemic lupus erythematosus	0.00858	0.0233	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Hydrocortisone—systemic lupus erythematosus	0.00858	0.0233	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Cyclosporine—systemic lupus erythematosus	0.0081	0.022	CbGbCtD
Tretinoin—CYP3A7—Cyclosporine—systemic lupus erythematosus	0.0081	0.022	CbGbCtD
Tretinoin—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.00802	0.0218	CbGbCtD
Tretinoin—CYP2A6—Dexamethasone—systemic lupus erythematosus	0.0078	0.0212	CbGbCtD
Tretinoin—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.00771	0.021	CbGbCtD
Tretinoin—CYP1A1—Dexamethasone—systemic lupus erythematosus	0.00667	0.0181	CbGbCtD
Tretinoin—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.00643	0.0175	CbGbCtD
Tretinoin—CYP2C9—Dapsone—systemic lupus erythematosus	0.0062	0.0169	CbGbCtD
Tretinoin—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.00619	0.0168	CbGbCtD
Tretinoin—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.00608	0.0165	CbGbCtD
Tretinoin—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.00584	0.0159	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Dexamethasone—systemic lupus erythematosus	0.00533	0.0145	CbGbCtD
Tretinoin—CYP3A7—Dexamethasone—systemic lupus erythematosus	0.00533	0.0145	CbGbCtD
Tretinoin—CYP2B6—Dexamethasone—systemic lupus erythematosus	0.00508	0.0138	CbGbCtD
Tretinoin—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00412	0.0112	CbGbCtD
Tretinoin—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00407	0.0111	CbGbCtD
Tretinoin—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.004	0.0109	CbGbCtD
Tretinoin—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00385	0.0105	CbGbCtD
Tretinoin—CYP2C9—cardial valve—systemic lupus erythematosus	0.00375	0.0728	CbGeAlD
Tretinoin—CYP3A4—Dapsone—systemic lupus erythematosus	0.00361	0.00981	CbGbCtD
Tretinoin—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00313	0.00851	CbGbCtD
Tretinoin—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00313	0.00851	CbGbCtD
Tretinoin—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00268	0.0073	CbGbCtD
Tretinoin—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00268	0.0073	CbGbCtD
Tretinoin—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00265	0.0072	CbGbCtD
Tretinoin—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00251	0.00683	CbGbCtD
Tretinoin—CYP3A4—Prednisone—systemic lupus erythematosus	0.0025	0.0068	CbGbCtD
Tretinoin—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00237	0.00645	CbGbCtD
Tretinoin—GPRC5A—kidney—systemic lupus erythematosus	0.00234	0.0455	CbGeAlD
Tretinoin—GPRC5A—lung—systemic lupus erythematosus	0.00166	0.0322	CbGeAlD
Tretinoin—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00156	0.00425	CbGbCtD
Tretinoin—Isotretinoin—RXRA—systemic lupus erythematosus	0.00148	0.361	CrCbGaD
Tretinoin—Acitretin—RXRA—systemic lupus erythematosus	0.00126	0.307	CrCbGaD
Tretinoin—RARRES1—skin of body—systemic lupus erythematosus	0.00126	0.0244	CbGeAlD
Tretinoin—Alitretinoin—RXRA—systemic lupus erythematosus	0.00121	0.294	CrCbGaD
Tretinoin—ALDH1A2—nephron tubule—systemic lupus erythematosus	0.00103	0.0201	CbGeAlD
Tretinoin—CRABP1—connective tissue—systemic lupus erythematosus	0.00103	0.02	CbGeAlD
Tretinoin—RARRES1—tendon—systemic lupus erythematosus	0.000957	0.0186	CbGeAlD
Tretinoin—CRABP2—connective tissue—systemic lupus erythematosus	0.000932	0.0181	CbGeAlD
Tretinoin—CRABP1—skin of body—systemic lupus erythematosus	0.000931	0.0181	CbGeAlD
Tretinoin—ALDH1A2—cortex of kidney—systemic lupus erythematosus	0.000886	0.0172	CbGeAlD
Tretinoin—CYP4A11—kidney—systemic lupus erythematosus	0.000877	0.017	CbGeAlD
Tretinoin—CRABP1—cortex of kidney—systemic lupus erythematosus	0.000854	0.0166	CbGeAlD
Tretinoin—CYP4A11—cortex of kidney—systemic lupus erythematosus	0.000854	0.0166	CbGeAlD
Tretinoin—CRABP2—skin of body—systemic lupus erythematosus	0.000842	0.0163	CbGeAlD
Tretinoin—RARRES1—lung—systemic lupus erythematosus	0.00084	0.0163	CbGeAlD
Tretinoin—CYP2C9—urine—systemic lupus erythematosus	0.00081	0.0157	CbGeAlD
Tretinoin—RXRA—kidney—systemic lupus erythematosus	0.00079	0.0153	CbGeAlD
Tretinoin—ALDH1A1—connective tissue—systemic lupus erythematosus	0.000777	0.0151	CbGeAlD
Tretinoin—ALDH1A1—nephron tubule—systemic lupus erythematosus	0.000752	0.0146	CbGeAlD
Tretinoin—NR0B1—lung—systemic lupus erythematosus	0.000723	0.014	CbGeAlD
Tretinoin—CRABP1—tendon—systemic lupus erythematosus	0.000708	0.0137	CbGeAlD
Tretinoin—ALDH1A1—skin of body—systemic lupus erythematosus	0.000701	0.0136	CbGeAlD
Tretinoin—ALDH1A1—kidney—systemic lupus erythematosus	0.000661	0.0128	CbGeAlD
Tretinoin—ALDH1A2—lung—systemic lupus erythematosus	0.000644	0.0125	CbGeAlD
Tretinoin—ALDH1A1—cortex of kidney—systemic lupus erythematosus	0.000644	0.0125	CbGeAlD
Tretinoin—CRABP2—tendon—systemic lupus erythematosus	0.000641	0.0124	CbGeAlD
Tretinoin—CYP3A4—urine—systemic lupus erythematosus	0.000617	0.012	CbGeAlD
Tretinoin—RARG—skin of body—systemic lupus erythematosus	0.000614	0.0119	CbGeAlD
Tretinoin—ALDH1A2—nervous system—systemic lupus erythematosus	0.000597	0.0116	CbGeAlD
Tretinoin—CRABP1—nervous system—systemic lupus erythematosus	0.000576	0.0112	CbGeAlD
Tretinoin—ALDH1A2—central nervous system—systemic lupus erythematosus	0.000574	0.0111	CbGeAlD
Tretinoin—RARB—tendon—systemic lupus erythematosus	0.000573	0.0111	CbGeAlD
Tretinoin—ALDH1A1—lymphoid tissue—systemic lupus erythematosus	0.000568	0.011	CbGeAlD
Tretinoin—CRABP2—lung—systemic lupus erythematosus	0.000562	0.0109	CbGeAlD
Tretinoin—RXRG—tendon—systemic lupus erythematosus	0.00056	0.0109	CbGeAlD
Tretinoin—CRABP1—central nervous system—systemic lupus erythematosus	0.000554	0.0108	CbGeAlD
Tretinoin—RARA—kidney—systemic lupus erythematosus	0.000544	0.0106	CbGeAlD
Tretinoin—CYP3A7-CYP3A51P—nephron tubule—systemic lupus erythematosus	0.000535	0.0104	CbGeAlD
Tretinoin—ALDH1A1—tendon—systemic lupus erythematosus	0.000534	0.0104	CbGeAlD
Tretinoin—RXRB—tendon—systemic lupus erythematosus	0.000526	0.0102	CbGeAlD
Tretinoin—CRABP2—nervous system—systemic lupus erythematosus	0.000521	0.0101	CbGeAlD
Tretinoin—RXRA—nervous system—systemic lupus erythematosus	0.000518	0.0101	CbGeAlD
Tretinoin—ALDH1A1—bone marrow—systemic lupus erythematosus	0.000517	0.01	CbGeAlD
Tretinoin—RARB—lung—systemic lupus erythematosus	0.000503	0.00976	CbGeAlD
Tretinoin—CRABP2—central nervous system—systemic lupus erythematosus	0.000501	0.00973	CbGeAlD
Tretinoin—RXRA—central nervous system—systemic lupus erythematosus	0.000499	0.00968	CbGeAlD
Tretinoin—CYP2C8—blood plasma—systemic lupus erythematosus	0.000476	0.00923	CbGeAlD
Tretinoin—ALDH1A1—lung—systemic lupus erythematosus	0.000468	0.00909	CbGeAlD
Tretinoin—RARA—lymphoid tissue—systemic lupus erythematosus	0.000467	0.00907	CbGeAlD
Tretinoin—RARG—tendon—systemic lupus erythematosus	0.000467	0.00907	CbGeAlD
Tretinoin—RXRB—lung—systemic lupus erythematosus	0.000462	0.00897	CbGeAlD
Tretinoin—CYP3A7-CYP3A51P—cortex of kidney—systemic lupus erythematosus	0.000458	0.00888	CbGeAlD
Tretinoin—RXRG—nervous system—systemic lupus erythematosus	0.000455	0.00883	CbGeAlD
Tretinoin—RARA—tendon—systemic lupus erythematosus	0.000439	0.00853	CbGeAlD
Tretinoin—RXRG—central nervous system—systemic lupus erythematosus	0.000438	0.0085	CbGeAlD
Tretinoin—ALDH1A1—nervous system—systemic lupus erythematosus	0.000434	0.00842	CbGeAlD
Tretinoin—CYP3A5—blood plasma—systemic lupus erythematosus	0.000429	0.00833	CbGeAlD
Tretinoin—RXRB—nervous system—systemic lupus erythematosus	0.000428	0.0083	CbGeAlD
Tretinoin—CYP2B6—blood plasma—systemic lupus erythematosus	0.000427	0.00828	CbGeAlD
Tretinoin—RARA—bone marrow—systemic lupus erythematosus	0.000426	0.00826	CbGeAlD
Tretinoin—CYP2C9—blood plasma—systemic lupus erythematosus	0.000423	0.0082	CbGeAlD
Tretinoin—ALDH1A1—central nervous system—systemic lupus erythematosus	0.000418	0.0081	CbGeAlD
Tretinoin—RXRB—central nervous system—systemic lupus erythematosus	0.000412	0.00799	CbGeAlD
Tretinoin—RARG—lung—systemic lupus erythematosus	0.00041	0.00796	CbGeAlD
Tretinoin—RARA—lung—systemic lupus erythematosus	0.000386	0.00748	CbGeAlD
Tretinoin—RARG—nervous system—systemic lupus erythematosus	0.00038	0.00737	CbGeAlD
Tretinoin—RARG—central nervous system—systemic lupus erythematosus	0.000366	0.0071	CbGeAlD
Tretinoin—RARA—nervous system—systemic lupus erythematosus	0.000357	0.00693	CbGeAlD
Tretinoin—RARA—central nervous system—systemic lupus erythematosus	0.000344	0.00667	CbGeAlD
Tretinoin—CYP3A4—blood plasma—systemic lupus erythematosus	0.000322	0.00625	CbGeAlD
Tretinoin—CYP2A6—lung—systemic lupus erythematosus	0.000272	0.00528	CbGeAlD
Tretinoin—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000221	0.0043	CbGeAlD
Tretinoin—CYP2B6—nephron tubule—systemic lupus erythematosus	0.00022	0.00427	CbGeAlD
Tretinoin—CYP2C8—kidney—systemic lupus erythematosus	0.000216	0.00418	CbGeAlD
Tretinoin—CYP1A1—skin of body—systemic lupus erythematosus	0.000211	0.0041	CbGeAlD
Tretinoin—CYP2B6—skin of body—systemic lupus erythematosus	0.000205	0.00398	CbGeAlD
Tretinoin—CYP1A1—kidney—systemic lupus erythematosus	0.000199	0.00386	CbGeAlD
Tretinoin—CYP3A5—kidney—systemic lupus erythematosus	0.000195	0.00378	CbGeAlD
Tretinoin—CYP2B6—kidney—systemic lupus erythematosus	0.000193	0.00375	CbGeAlD
Tretinoin—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.00019	0.00368	CbGeAlD
Tretinoin—CYP2B6—lymphoid tissue—systemic lupus erythematosus	0.000166	0.00322	CbGeAlD
Tretinoin—Acitretin—ALB—systemic lupus erythematosus	0.000161	0.039	CrCbGaD
Tretinoin—CYP3A4—kidney—systemic lupus erythematosus	0.000146	0.00283	CbGeAlD
Tretinoin—CYP1A1—lung—systemic lupus erythematosus	0.000141	0.00274	CbGeAlD
Tretinoin—CYP3A5—lung—systemic lupus erythematosus	0.000138	0.00268	CbGeAlD
Tretinoin—CYP2B6—lung—systemic lupus erythematosus	0.000137	0.00266	CbGeAlD
Tretinoin—CYP1A1—nervous system—systemic lupus erythematosus	0.000131	0.00253	CbGeAlD
Tretinoin—CYP2B6—nervous system—systemic lupus erythematosus	0.000127	0.00246	CbGeAlD
Tretinoin—CYP1A1—central nervous system—systemic lupus erythematosus	0.000126	0.00244	CbGeAlD
Tretinoin—CYP2B6—central nervous system—systemic lupus erythematosus	0.000122	0.00237	CbGeAlD
Tretinoin—CYP3A4—nervous system—systemic lupus erythematosus	9.58e-05	0.00186	CbGeAlD
Tretinoin—CYP3A4—central nervous system—systemic lupus erythematosus	9.23e-05	0.00179	CbGeAlD
Tretinoin—RARA—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	3.17e-05	0.000515	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	3.17e-05	0.000515	CbGpPWpGaD
Tretinoin—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.12e-05	0.000507	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	3.11e-05	0.000505	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—JUNB—systemic lupus erythematosus	3.09e-05	0.000501	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—IL6—systemic lupus erythematosus	3.07e-05	0.000498	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	3.07e-05	0.000498	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—HIST2H2AC—systemic lupus erythematosus	3.06e-05	0.000496	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—HIST2H2AC—systemic lupus erythematosus	3.06e-05	0.000496	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MTA2—systemic lupus erythematosus	3.03e-05	0.000492	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic lupus erythematosus	3.03e-05	0.000492	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	3e-05	0.000487	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	3e-05	0.000487	CbGpPWpGaD
Tretinoin—CYP2A6—Biological oxidations—RXRA—systemic lupus erythematosus	2.98e-05	0.000484	CbGpPWpGaD
Tretinoin—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	2.97e-05	0.000213	CcSEcCtD
Tretinoin—Fatigue—Hydrocortisone—systemic lupus erythematosus	2.97e-05	0.000213	CcSEcCtD
Tretinoin—CYP1A1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.97e-05	0.000481	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	2.96e-05	0.00048	CbGpPWpGaD
Tretinoin—Vision blurred—Prednisone—systemic lupus erythematosus	2.96e-05	0.000212	CcSEcCtD
Tretinoin—Urethral disorder—Methotrexate—systemic lupus erythematosus	2.95e-05	0.000212	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	2.95e-05	0.000212	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	2.94e-05	0.000211	CcSEcCtD
Tretinoin—Pain—Hydrocortisone—systemic lupus erythematosus	2.94e-05	0.000211	CcSEcCtD
Tretinoin—Oedema—Dexamethasone—systemic lupus erythematosus	2.94e-05	0.000211	CcSEcCtD
Tretinoin—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	2.94e-05	0.000211	CcSEcCtD
Tretinoin—Oedema—Betamethasone—systemic lupus erythematosus	2.94e-05	0.000211	CcSEcCtD
Tretinoin—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	2.94e-05	0.000211	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	2.94e-05	0.000477	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	2.94e-05	0.000476	CbGpPWpGaD
Tretinoin—Insomnia—Triamcinolone—systemic lupus erythematosus	2.93e-05	0.00021	CcSEcCtD
Tretinoin—Insomnia—Methylprednisolone—systemic lupus erythematosus	2.92e-05	0.00021	CcSEcCtD
Tretinoin—Infection—Betamethasone—systemic lupus erythematosus	2.92e-05	0.000209	CcSEcCtD
Tretinoin—Infection—Dexamethasone—systemic lupus erythematosus	2.92e-05	0.000209	CcSEcCtD
Tretinoin—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	2.92e-05	0.000473	CbGpPWpGaD
Tretinoin—Ill-defined disorder—Prednisone—systemic lupus erythematosus	2.91e-05	0.000209	CcSEcCtD
Tretinoin—Paraesthesia—Triamcinolone—systemic lupus erythematosus	2.91e-05	0.000209	CcSEcCtD
Tretinoin—Feeling abnormal—Prednisolone—systemic lupus erythematosus	2.9e-05	0.000208	CcSEcCtD
Tretinoin—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	2.9e-05	0.000208	CcSEcCtD
Tretinoin—Visual impairment—Methotrexate—systemic lupus erythematosus	2.9e-05	0.000208	CcSEcCtD
Tretinoin—Anaemia—Prednisone—systemic lupus erythematosus	2.9e-05	0.000208	CcSEcCtD
Tretinoin—Shock—Betamethasone—systemic lupus erythematosus	2.89e-05	0.000207	CcSEcCtD
Tretinoin—Shock—Dexamethasone—systemic lupus erythematosus	2.89e-05	0.000207	CcSEcCtD
Tretinoin—Dyspnoea—Triamcinolone—systemic lupus erythematosus	2.89e-05	0.000207	CcSEcCtD
Tretinoin—RARA—Adipogenesis—IL6—systemic lupus erythematosus	2.88e-05	0.000468	CbGpPWpGaD
Tretinoin—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	2.88e-05	0.000207	CcSEcCtD
Tretinoin—Nervous system disorder—Betamethasone—systemic lupus erythematosus	2.88e-05	0.000207	CcSEcCtD
Tretinoin—Agitation—Prednisone—systemic lupus erythematosus	2.88e-05	0.000207	CcSEcCtD
Tretinoin—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	2.88e-05	0.000206	CcSEcCtD
Tretinoin—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	2.88e-05	0.000206	CcSEcCtD
Tretinoin—Tachycardia—Dexamethasone—systemic lupus erythematosus	2.87e-05	0.000206	CcSEcCtD
Tretinoin—Tachycardia—Betamethasone—systemic lupus erythematosus	2.87e-05	0.000206	CcSEcCtD
Tretinoin—RARG—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	2.86e-05	0.000464	CbGpPWpGaD
Tretinoin—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	2.85e-05	0.000204	CcSEcCtD
Tretinoin—Dyspepsia—Triamcinolone—systemic lupus erythematosus	2.85e-05	0.000204	CcSEcCtD
Tretinoin—Erythema multiforme—Methotrexate—systemic lupus erythematosus	2.85e-05	0.000204	CcSEcCtD
Tretinoin—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	2.84e-05	0.000204	CcSEcCtD
Tretinoin—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	2.84e-05	0.000204	CcSEcCtD
Tretinoin—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	2.84e-05	0.000204	CcSEcCtD
Tretinoin—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	2.83e-05	0.000203	CcSEcCtD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—systemic lupus erythematosus	2.83e-05	0.00046	CbGpPWpGaD
Tretinoin—Malaise—Prednisone—systemic lupus erythematosus	2.83e-05	0.000203	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	2.81e-05	0.000457	CbGpPWpGaD
Tretinoin—Eye disorder—Methotrexate—systemic lupus erythematosus	2.81e-05	0.000202	CcSEcCtD
Tretinoin—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	2.81e-05	0.000202	CcSEcCtD
Tretinoin—Syncope—Prednisone—systemic lupus erythematosus	2.81e-05	0.000202	CcSEcCtD
Tretinoin—Tinnitus—Methotrexate—systemic lupus erythematosus	2.81e-05	0.000201	CcSEcCtD
Tretinoin—Anorexia—Betamethasone—systemic lupus erythematosus	2.8e-05	0.000201	CcSEcCtD
Tretinoin—Anorexia—Dexamethasone—systemic lupus erythematosus	2.8e-05	0.000201	CcSEcCtD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.8e-05	0.000454	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.8e-05	0.000454	CbGpPWpGaD
Tretinoin—Urticaria—Prednisolone—systemic lupus erythematosus	2.8e-05	0.000201	CcSEcCtD
Tretinoin—Fatigue—Triamcinolone—systemic lupus erythematosus	2.79e-05	0.0002	CcSEcCtD
Tretinoin—Fatigue—Methylprednisolone—systemic lupus erythematosus	2.79e-05	0.0002	CcSEcCtD
Tretinoin—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	2.78e-05	0.000199	CcSEcCtD
Tretinoin—Asthenia—Cyclosporine—systemic lupus erythematosus	2.78e-05	0.000199	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	2.77e-05	0.00045	CbGpPWpGaD
Tretinoin—Pain—Triamcinolone—systemic lupus erythematosus	2.77e-05	0.000199	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—LYN—systemic lupus erythematosus	2.76e-05	0.000448	CbGpPWpGaD
Tretinoin—Loss of consciousness—Prednisone—systemic lupus erythematosus	2.76e-05	0.000198	CcSEcCtD
Tretinoin—Hypotension—Dexamethasone—systemic lupus erythematosus	2.75e-05	0.000197	CcSEcCtD
Tretinoin—Hypotension—Betamethasone—systemic lupus erythematosus	2.75e-05	0.000197	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.74e-05	0.000445	CbGpPWpGaD
Tretinoin—Pruritus—Cyclosporine—systemic lupus erythematosus	2.74e-05	0.000196	CcSEcCtD
Tretinoin—Urticaria—Hydrocortisone—systemic lupus erythematosus	2.73e-05	0.000196	CcSEcCtD
Tretinoin—Angiopathy—Methotrexate—systemic lupus erythematosus	2.73e-05	0.000196	CcSEcCtD
Tretinoin—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	2.72e-05	0.000195	CcSEcCtD
Tretinoin—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	2.72e-05	0.000195	CcSEcCtD
Tretinoin—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.72e-05	0.000441	CbGpPWpGaD
Tretinoin—Convulsion—Prednisone—systemic lupus erythematosus	2.72e-05	0.000195	CcSEcCtD
Tretinoin—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	2.71e-05	0.000194	CcSEcCtD
Tretinoin—Hypertension—Prednisone—systemic lupus erythematosus	2.71e-05	0.000194	CcSEcCtD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	2.7e-05	0.000439	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—RXRA—systemic lupus erythematosus	2.7e-05	0.000439	CbGpPWpGaD
Tretinoin—Chills—Methotrexate—systemic lupus erythematosus	2.7e-05	0.000194	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	2.68e-05	0.000192	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	2.68e-05	0.000192	CcSEcCtD
Tretinoin—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	2.67e-05	0.000192	CcSEcCtD
Tretinoin—Arthralgia—Prednisone—systemic lupus erythematosus	2.67e-05	0.000191	CcSEcCtD
Tretinoin—Myalgia—Prednisone—systemic lupus erythematosus	2.67e-05	0.000191	CcSEcCtD
Tretinoin—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	2.67e-05	0.000191	CcSEcCtD
Tretinoin—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	2.66e-05	0.000191	CcSEcCtD
Tretinoin—Anxiety—Prednisone—systemic lupus erythematosus	2.66e-05	0.000191	CcSEcCtD
Tretinoin—Alopecia—Methotrexate—systemic lupus erythematosus	2.66e-05	0.000191	CcSEcCtD
Tretinoin—Insomnia—Dexamethasone—systemic lupus erythematosus	2.66e-05	0.000191	CcSEcCtD
Tretinoin—Insomnia—Betamethasone—systemic lupus erythematosus	2.66e-05	0.000191	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	2.65e-05	0.00019	CcSEcCtD
Tretinoin—Diarrhoea—Cyclosporine—systemic lupus erythematosus	2.65e-05	0.00019	CcSEcCtD
Tretinoin—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	2.64e-05	0.000189	CcSEcCtD
Tretinoin—Paraesthesia—Dexamethasone—systemic lupus erythematosus	2.64e-05	0.000189	CcSEcCtD
Tretinoin—Paraesthesia—Betamethasone—systemic lupus erythematosus	2.64e-05	0.000189	CcSEcCtD
Tretinoin—Discomfort—Prednisone—systemic lupus erythematosus	2.64e-05	0.000189	CcSEcCtD
Tretinoin—Mental disorder—Methotrexate—systemic lupus erythematosus	2.64e-05	0.000189	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	2.64e-05	0.000428	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	2.64e-05	0.000428	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.63e-05	0.000426	CbGpPWpGaD
Tretinoin—RXRA—PPARA activates gene expression—EP300—systemic lupus erythematosus	2.62e-05	0.000426	CbGpPWpGaD
Tretinoin—Malnutrition—Methotrexate—systemic lupus erythematosus	2.62e-05	0.000188	CcSEcCtD
Tretinoin—Erythema—Methotrexate—systemic lupus erythematosus	2.62e-05	0.000188	CcSEcCtD
Tretinoin—RXRG—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	2.61e-05	0.000424	CbGpPWpGaD
Tretinoin—Hypersensitivity—Prednisolone—systemic lupus erythematosus	2.59e-05	0.000186	CcSEcCtD
Tretinoin—Dyspepsia—Betamethasone—systemic lupus erythematosus	2.59e-05	0.000185	CcSEcCtD
Tretinoin—Dyspepsia—Dexamethasone—systemic lupus erythematosus	2.59e-05	0.000185	CcSEcCtD
Tretinoin—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	2.58e-05	0.000185	CcSEcCtD
Tretinoin—Urticaria—Triamcinolone—systemic lupus erythematosus	2.57e-05	0.000184	CcSEcCtD
Tretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	2.57e-05	0.000417	CbGpPWpGaD
Tretinoin—Urticaria—Methylprednisolone—systemic lupus erythematosus	2.57e-05	0.000184	CcSEcCtD
Tretinoin—RARB—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	2.56e-05	0.000416	CbGpPWpGaD
Tretinoin—Body temperature increased—Triamcinolone—systemic lupus erythematosus	2.56e-05	0.000184	CcSEcCtD
Tretinoin—Dizziness—Cyclosporine—systemic lupus erythematosus	2.56e-05	0.000184	CcSEcCtD
Tretinoin—Oedema—Prednisone—systemic lupus erythematosus	2.56e-05	0.000184	CcSEcCtD
Tretinoin—Anaphylactic shock—Prednisone—systemic lupus erythematosus	2.56e-05	0.000184	CcSEcCtD
Tretinoin—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	2.55e-05	0.000183	CcSEcCtD
Tretinoin—Decreased appetite—Dexamethasone—systemic lupus erythematosus	2.55e-05	0.000183	CcSEcCtD
Tretinoin—Decreased appetite—Betamethasone—systemic lupus erythematosus	2.55e-05	0.000183	CcSEcCtD
Tretinoin—Infection—Prednisone—systemic lupus erythematosus	2.54e-05	0.000182	CcSEcCtD
Tretinoin—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	2.54e-05	0.000412	CbGpPWpGaD
Tretinoin—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	2.54e-05	0.000182	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	2.54e-05	0.000182	CcSEcCtD
Tretinoin—Back pain—Methotrexate—systemic lupus erythematosus	2.53e-05	0.000182	CcSEcCtD
Tretinoin—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	2.53e-05	0.000182	CcSEcCtD
Tretinoin—Fatigue—Betamethasone—systemic lupus erythematosus	2.53e-05	0.000182	CcSEcCtD
Tretinoin—Fatigue—Dexamethasone—systemic lupus erythematosus	2.53e-05	0.000182	CcSEcCtD
Tretinoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	2.53e-05	0.00041	CbGpPWpGaD
Tretinoin—Shock—Prednisone—systemic lupus erythematosus	2.52e-05	0.000181	CcSEcCtD
Tretinoin—Pain—Betamethasone—systemic lupus erythematosus	2.51e-05	0.00018	CcSEcCtD
Tretinoin—Pain—Dexamethasone—systemic lupus erythematosus	2.51e-05	0.00018	CcSEcCtD
Tretinoin—Nervous system disorder—Prednisone—systemic lupus erythematosus	2.51e-05	0.00018	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—RXRA—systemic lupus erythematosus	2.51e-05	0.000407	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—RXRA—systemic lupus erythematosus	2.51e-05	0.000407	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—RXRA—systemic lupus erythematosus	2.51e-05	0.000407	CbGpPWpGaD
Tretinoin—Tachycardia—Prednisone—systemic lupus erythematosus	2.5e-05	0.000179	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.5e-05	0.000405	CbGpPWpGaD
Tretinoin—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	2.5e-05	0.000179	CcSEcCtD
Tretinoin—RARG—Gene Expression—JUNB—systemic lupus erythematosus	2.49e-05	0.000404	CbGpPWpGaD
Tretinoin—Skin disorder—Prednisone—systemic lupus erythematosus	2.49e-05	0.000178	CcSEcCtD
Tretinoin—Hyperhidrosis—Prednisone—systemic lupus erythematosus	2.47e-05	0.000177	CcSEcCtD
Tretinoin—Vision blurred—Methotrexate—systemic lupus erythematosus	2.47e-05	0.000177	CcSEcCtD
Tretinoin—Asthenia—Hydrocortisone—systemic lupus erythematosus	2.47e-05	0.000177	CcSEcCtD
Tretinoin—Vomiting—Cyclosporine—systemic lupus erythematosus	2.46e-05	0.000176	CcSEcCtD
Tretinoin—RARA—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	2.46e-05	0.000399	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	2.46e-05	0.000399	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—VDR—systemic lupus erythematosus	2.45e-05	0.000397	CbGpPWpGaD
Tretinoin—Rash—Cyclosporine—systemic lupus erythematosus	2.44e-05	0.000175	CcSEcCtD
Tretinoin—Anorexia—Prednisone—systemic lupus erythematosus	2.44e-05	0.000175	CcSEcCtD
Tretinoin—Dermatitis—Cyclosporine—systemic lupus erythematosus	2.44e-05	0.000175	CcSEcCtD
Tretinoin—Pruritus—Hydrocortisone—systemic lupus erythematosus	2.43e-05	0.000174	CcSEcCtD
Tretinoin—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	2.43e-05	0.000174	CcSEcCtD
Tretinoin—Headache—Cyclosporine—systemic lupus erythematosus	2.42e-05	0.000174	CcSEcCtD
Tretinoin—Anaemia—Methotrexate—systemic lupus erythematosus	2.42e-05	0.000174	CcSEcCtD
Tretinoin—Feeling abnormal—Betamethasone—systemic lupus erythematosus	2.42e-05	0.000174	CcSEcCtD
Tretinoin—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	2.42e-05	0.000174	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—CDKN1A—systemic lupus erythematosus	2.41e-05	0.000391	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—RXRA—systemic lupus erythematosus	2.41e-05	0.000391	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	2.4e-05	0.000172	CcSEcCtD
Tretinoin—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	2.4e-05	0.000172	CcSEcCtD
Tretinoin—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	2.4e-05	0.000172	CcSEcCtD
Tretinoin—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	2.39e-05	0.000171	CcSEcCtD
Tretinoin—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	2.38e-05	0.000171	CcSEcCtD
Tretinoin—Rash—Mycophenolate mofetil—systemic lupus erythematosus	2.38e-05	0.000171	CcSEcCtD
Tretinoin—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	2.38e-05	0.000171	CcSEcCtD
Tretinoin—Headache—Mycophenolate mofetil—systemic lupus erythematosus	2.37e-05	0.00017	CcSEcCtD
Tretinoin—Malaise—Methotrexate—systemic lupus erythematosus	2.36e-05	0.000169	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—PTPRC—systemic lupus erythematosus	2.36e-05	0.000383	CbGpPWpGaD
Tretinoin—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	2.35e-05	0.000169	CcSEcCtD
Tretinoin—CYP3A5—Biological oxidations—RXRA—systemic lupus erythematosus	2.35e-05	0.000382	CbGpPWpGaD
Tretinoin—Urticaria—Betamethasone—systemic lupus erythematosus	2.33e-05	0.000167	CcSEcCtD
Tretinoin—Urticaria—Dexamethasone—systemic lupus erythematosus	2.33e-05	0.000167	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	2.33e-05	0.000167	CcSEcCtD
Tretinoin—Dizziness—Prednisolone—systemic lupus erythematosus	2.33e-05	0.000167	CcSEcCtD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.33e-05	0.000378	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.33e-05	0.000378	CbGpPWpGaD
Tretinoin—Asthenia—Triamcinolone—systemic lupus erythematosus	2.32e-05	0.000167	CcSEcCtD
Tretinoin—Body temperature increased—Betamethasone—systemic lupus erythematosus	2.32e-05	0.000167	CcSEcCtD
Tretinoin—Abdominal pain—Dexamethasone—systemic lupus erythematosus	2.32e-05	0.000167	CcSEcCtD
Tretinoin—Body temperature increased—Dexamethasone—systemic lupus erythematosus	2.32e-05	0.000167	CcSEcCtD
Tretinoin—Abdominal pain—Betamethasone—systemic lupus erythematosus	2.32e-05	0.000167	CcSEcCtD
Tretinoin—Asthenia—Methylprednisolone—systemic lupus erythematosus	2.32e-05	0.000166	CcSEcCtD
Tretinoin—RXRA—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.31e-05	0.000376	CbGpPWpGaD
Tretinoin—Insomnia—Prednisone—systemic lupus erythematosus	2.31e-05	0.000166	CcSEcCtD
Tretinoin—Nausea—Cyclosporine—systemic lupus erythematosus	2.3e-05	0.000165	CcSEcCtD
Tretinoin—Paraesthesia—Prednisone—systemic lupus erythematosus	2.3e-05	0.000165	CcSEcCtD
Tretinoin—CYP4A11—NRF2 pathway—TGFB1—systemic lupus erythematosus	2.29e-05	0.000372	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	2.29e-05	0.000372	CbGpPWpGaD
Tretinoin—Pruritus—Triamcinolone—systemic lupus erythematosus	2.29e-05	0.000164	CcSEcCtD
Tretinoin—Cough—Methotrexate—systemic lupus erythematosus	2.29e-05	0.000164	CcSEcCtD
Tretinoin—Pruritus—Methylprednisolone—systemic lupus erythematosus	2.29e-05	0.000164	CcSEcCtD
Tretinoin—RXRG—Gene Expression—JUNB—systemic lupus erythematosus	2.27e-05	0.000369	CbGpPWpGaD
Tretinoin—Dizziness—Hydrocortisone—systemic lupus erythematosus	2.27e-05	0.000163	CcSEcCtD
Tretinoin—Convulsion—Methotrexate—systemic lupus erythematosus	2.27e-05	0.000163	CcSEcCtD
Tretinoin—Dyspepsia—Prednisone—systemic lupus erythematosus	2.25e-05	0.000162	CcSEcCtD
Tretinoin—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	2.24e-05	0.000161	CcSEcCtD
Tretinoin—Myalgia—Methotrexate—systemic lupus erythematosus	2.23e-05	0.00016	CcSEcCtD
Tretinoin—Chest pain—Methotrexate—systemic lupus erythematosus	2.23e-05	0.00016	CcSEcCtD
Tretinoin—Arthralgia—Methotrexate—systemic lupus erythematosus	2.23e-05	0.00016	CcSEcCtD
Tretinoin—RARB—Gene Expression—JUNB—systemic lupus erythematosus	2.23e-05	0.000362	CbGpPWpGaD
Tretinoin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	2.23e-05	0.000362	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—ADIPOQ—systemic lupus erythematosus	2.23e-05	0.000362	CbGpPWpGaD
Tretinoin—Decreased appetite—Prednisone—systemic lupus erythematosus	2.22e-05	0.00016	CcSEcCtD
Tretinoin—CYP1A1—Biological oxidations—RXRA—systemic lupus erythematosus	2.22e-05	0.000361	CbGpPWpGaD
Tretinoin—Rash—Prednisolone—systemic lupus erythematosus	2.22e-05	0.000159	CcSEcCtD
Tretinoin—Dermatitis—Prednisolone—systemic lupus erythematosus	2.22e-05	0.000159	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	2.22e-05	0.000159	CcSEcCtD
Tretinoin—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.21e-05	0.000359	CbGpPWpGaD
Tretinoin—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	2.21e-05	0.000159	CcSEcCtD
Tretinoin—Fatigue—Prednisone—systemic lupus erythematosus	2.21e-05	0.000158	CcSEcCtD
Tretinoin—Headache—Prednisolone—systemic lupus erythematosus	2.21e-05	0.000158	CcSEcCtD
Tretinoin—Discomfort—Methotrexate—systemic lupus erythematosus	2.2e-05	0.000158	CcSEcCtD
Tretinoin—NR0B1—Gene Expression—NR3C1—systemic lupus erythematosus	2.2e-05	0.000358	CbGpPWpGaD
Tretinoin—Constipation—Prednisone—systemic lupus erythematosus	2.19e-05	0.000157	CcSEcCtD
Tretinoin—Vomiting—Hydrocortisone—systemic lupus erythematosus	2.19e-05	0.000157	CcSEcCtD
Tretinoin—RARG—Gene Expression—RXRA—systemic lupus erythematosus	2.18e-05	0.000354	CbGpPWpGaD
Tretinoin—Rash—Hydrocortisone—systemic lupus erythematosus	2.17e-05	0.000156	CcSEcCtD
Tretinoin—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.17e-05	0.000155	CcSEcCtD
Tretinoin—Confusional state—Methotrexate—systemic lupus erythematosus	2.16e-05	0.000155	CcSEcCtD
Tretinoin—Headache—Hydrocortisone—systemic lupus erythematosus	2.15e-05	0.000155	CcSEcCtD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.15e-05	0.000349	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	2.14e-05	0.000348	CbGpPWpGaD
Tretinoin—Dizziness—Triamcinolone—systemic lupus erythematosus	2.14e-05	0.000154	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	2.14e-05	0.000347	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.14e-05	0.000347	CbGpPWpGaD
Tretinoin—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	2.14e-05	0.000153	CcSEcCtD
Tretinoin—RARA—Gene Expression—JUNB—systemic lupus erythematosus	2.14e-05	0.000347	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—JUNB—systemic lupus erythematosus	2.14e-05	0.000347	CbGpPWpGaD
Tretinoin—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.14e-05	0.000153	CcSEcCtD
Tretinoin—Infection—Methotrexate—systemic lupus erythematosus	2.12e-05	0.000152	CcSEcCtD
Tretinoin—Feeling abnormal—Prednisone—systemic lupus erythematosus	2.11e-05	0.000151	CcSEcCtD
Tretinoin—Asthenia—Dexamethasone—systemic lupus erythematosus	2.11e-05	0.000151	CcSEcCtD
Tretinoin—Asthenia—Betamethasone—systemic lupus erythematosus	2.11e-05	0.000151	CcSEcCtD
Tretinoin—Nervous system disorder—Methotrexate—systemic lupus erythematosus	2.1e-05	0.00015	CcSEcCtD
Tretinoin—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.09e-05	0.00015	CcSEcCtD
Tretinoin—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.09e-05	0.00015	CcSEcCtD
Tretinoin—Nausea—Prednisolone—systemic lupus erythematosus	2.09e-05	0.00015	CcSEcCtD
Tretinoin—Pruritus—Dexamethasone—systemic lupus erythematosus	2.08e-05	0.000149	CcSEcCtD
Tretinoin—Pruritus—Betamethasone—systemic lupus erythematosus	2.08e-05	0.000149	CcSEcCtD
Tretinoin—Skin disorder—Methotrexate—systemic lupus erythematosus	2.08e-05	0.000149	CcSEcCtD
Tretinoin—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	2.07e-05	0.000148	CcSEcCtD
Tretinoin—Vomiting—Triamcinolone—systemic lupus erythematosus	2.06e-05	0.000148	CcSEcCtD
Tretinoin—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	2.06e-05	0.000334	CbGpPWpGaD
Tretinoin—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.05e-05	0.000147	CcSEcCtD
Tretinoin—RXRA—Gene Expression—TNFSF13—systemic lupus erythematosus	2.05e-05	0.000333	CbGpPWpGaD
Tretinoin—Nausea—Hydrocortisone—systemic lupus erythematosus	2.04e-05	0.000146	CcSEcCtD
Tretinoin—Rash—Triamcinolone—systemic lupus erythematosus	2.04e-05	0.000146	CcSEcCtD
Tretinoin—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.04e-05	0.000146	CcSEcCtD
Tretinoin—Anorexia—Methotrexate—systemic lupus erythematosus	2.04e-05	0.000146	CcSEcCtD
Tretinoin—Rash—Methylprednisolone—systemic lupus erythematosus	2.04e-05	0.000146	CcSEcCtD
Tretinoin—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	2.04e-05	0.000331	CbGpPWpGaD
Tretinoin—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.04e-05	0.000146	CcSEcCtD
Tretinoin—Urticaria—Prednisone—systemic lupus erythematosus	2.03e-05	0.000146	CcSEcCtD
Tretinoin—Headache—Triamcinolone—systemic lupus erythematosus	2.03e-05	0.000145	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.03e-05	0.000329	CbGpPWpGaD
Tretinoin—Headache—Methylprednisolone—systemic lupus erythematosus	2.02e-05	0.000145	CcSEcCtD
Tretinoin—Abdominal pain—Prednisone—systemic lupus erythematosus	2.02e-05	0.000145	CcSEcCtD
Tretinoin—Body temperature increased—Prednisone—systemic lupus erythematosus	2.02e-05	0.000145	CcSEcCtD
Tretinoin—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.01e-05	0.000144	CcSEcCtD
Tretinoin—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.01e-05	0.000144	CcSEcCtD
Tretinoin—CYP1A1—PPARA activates gene expression—PPARG—systemic lupus erythematosus	2.01e-05	0.000326	CbGpPWpGaD
Tretinoin—Hypotension—Methotrexate—systemic lupus erythematosus	2e-05	0.000143	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—TGFB1—systemic lupus erythematosus	2e-05	0.000324	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—RXRA—systemic lupus erythematosus	1.99e-05	0.000324	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—SNRPB—systemic lupus erythematosus	1.98e-05	0.000322	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—VDR—systemic lupus erythematosus	1.97e-05	0.00032	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	1.96e-05	0.000319	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—RXRA—systemic lupus erythematosus	1.95e-05	0.000317	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	1.95e-05	0.000317	CbGpPWpGaD
Tretinoin—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	1.95e-05	0.00014	CcSEcCtD
Tretinoin—Dizziness—Betamethasone—systemic lupus erythematosus	1.94e-05	0.000139	CcSEcCtD
Tretinoin—Dizziness—Dexamethasone—systemic lupus erythematosus	1.94e-05	0.000139	CcSEcCtD
Tretinoin—Insomnia—Methotrexate—systemic lupus erythematosus	1.93e-05	0.000139	CcSEcCtD
Tretinoin—Nausea—Triamcinolone—systemic lupus erythematosus	1.92e-05	0.000138	CcSEcCtD
Tretinoin—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	1.92e-05	0.000312	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.92e-05	0.000312	CbGpPWpGaD
Tretinoin—Paraesthesia—Methotrexate—systemic lupus erythematosus	1.92e-05	0.000138	CcSEcCtD
Tretinoin—Nausea—Methylprednisolone—systemic lupus erythematosus	1.92e-05	0.000138	CcSEcCtD
Tretinoin—Dyspnoea—Methotrexate—systemic lupus erythematosus	1.91e-05	0.000137	CcSEcCtD
Tretinoin—Somnolence—Methotrexate—systemic lupus erythematosus	1.9e-05	0.000136	CcSEcCtD
Tretinoin—Hypersensitivity—Prednisone—systemic lupus erythematosus	1.89e-05	0.000135	CcSEcCtD
Tretinoin—Dyspepsia—Methotrexate—systemic lupus erythematosus	1.88e-05	0.000135	CcSEcCtD
Tretinoin—RARA—Gene Expression—RXRA—systemic lupus erythematosus	1.87e-05	0.000304	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—RXRA—systemic lupus erythematosus	1.87e-05	0.000304	CbGpPWpGaD
Tretinoin—Vomiting—Betamethasone—systemic lupus erythematosus	1.87e-05	0.000134	CcSEcCtD
Tretinoin—Vomiting—Dexamethasone—systemic lupus erythematosus	1.87e-05	0.000134	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—TNF—systemic lupus erythematosus	1.86e-05	0.000302	CbGpPWpGaD
Tretinoin—Decreased appetite—Methotrexate—systemic lupus erythematosus	1.86e-05	0.000133	CcSEcCtD
Tretinoin—Rash—Dexamethasone—systemic lupus erythematosus	1.85e-05	0.000133	CcSEcCtD
Tretinoin—Rash—Betamethasone—systemic lupus erythematosus	1.85e-05	0.000133	CcSEcCtD
Tretinoin—Dermatitis—Betamethasone—systemic lupus erythematosus	1.85e-05	0.000133	CcSEcCtD
Tretinoin—Dermatitis—Dexamethasone—systemic lupus erythematosus	1.85e-05	0.000133	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	1.85e-05	0.000132	CcSEcCtD
Tretinoin—Fatigue—Methotrexate—systemic lupus erythematosus	1.84e-05	0.000132	CcSEcCtD
Tretinoin—Headache—Betamethasone—systemic lupus erythematosus	1.84e-05	0.000132	CcSEcCtD
Tretinoin—Headache—Dexamethasone—systemic lupus erythematosus	1.84e-05	0.000132	CcSEcCtD
Tretinoin—RXRA—Generic Transcription Pathway—VDR—systemic lupus erythematosus	1.84e-05	0.000298	CbGpPWpGaD
Tretinoin—Asthenia—Prednisone—systemic lupus erythematosus	1.84e-05	0.000132	CcSEcCtD
Tretinoin—Pain—Methotrexate—systemic lupus erythematosus	1.83e-05	0.000131	CcSEcCtD
Tretinoin—RXRA—NRF2 pathway—TGFB1—systemic lupus erythematosus	1.82e-05	0.000295	CbGpPWpGaD
Tretinoin—Pruritus—Prednisone—systemic lupus erythematosus	1.81e-05	0.00013	CcSEcCtD
Tretinoin—RXRG—Gene Expression—VDR—systemic lupus erythematosus	1.81e-05	0.000293	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—NR3C1—systemic lupus erythematosus	1.78e-05	0.000288	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.77e-05	0.000288	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—VDR—systemic lupus erythematosus	1.77e-05	0.000287	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	1.77e-05	0.000287	CbGpPWpGaD
Tretinoin—Feeling abnormal—Methotrexate—systemic lupus erythematosus	1.76e-05	0.000126	CcSEcCtD
Tretinoin—Diarrhoea—Prednisone—systemic lupus erythematosus	1.75e-05	0.000126	CcSEcCtD
Tretinoin—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	1.75e-05	0.000125	CcSEcCtD
Tretinoin—Nausea—Dexamethasone—systemic lupus erythematosus	1.75e-05	0.000125	CcSEcCtD
Tretinoin—Nausea—Betamethasone—systemic lupus erythematosus	1.75e-05	0.000125	CcSEcCtD
Tretinoin—CYP4A11—Metabolism—NAT2—systemic lupus erythematosus	1.71e-05	0.000277	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—PPARG—systemic lupus erythematosus	1.71e-05	0.000277	CbGpPWpGaD
Tretinoin—Urticaria—Methotrexate—systemic lupus erythematosus	1.7e-05	0.000122	CcSEcCtD
Tretinoin—RXRB—Gene Expression—VDR—systemic lupus erythematosus	1.7e-05	0.000275	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—VDR—systemic lupus erythematosus	1.7e-05	0.000275	CbGpPWpGaD
Tretinoin—Dizziness—Prednisone—systemic lupus erythematosus	1.69e-05	0.000121	CcSEcCtD
Tretinoin—Abdominal pain—Methotrexate—systemic lupus erythematosus	1.69e-05	0.000121	CcSEcCtD
Tretinoin—Body temperature increased—Methotrexate—systemic lupus erythematosus	1.69e-05	0.000121	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.69e-05	0.000274	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	1.66e-05	0.000269	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	1.65e-05	0.000268	CbGpPWpGaD
Tretinoin—Vomiting—Prednisone—systemic lupus erythematosus	1.63e-05	0.000117	CcSEcCtD
Tretinoin—RXRG—Gene Expression—NR3C1—systemic lupus erythematosus	1.62e-05	0.000264	CbGpPWpGaD
Tretinoin—Rash—Prednisone—systemic lupus erythematosus	1.61e-05	0.000116	CcSEcCtD
Tretinoin—Dermatitis—Prednisone—systemic lupus erythematosus	1.61e-05	0.000116	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—JAK1—systemic lupus erythematosus	1.61e-05	0.000261	CbGpPWpGaD
Tretinoin—Headache—Prednisone—systemic lupus erythematosus	1.6e-05	0.000115	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.6e-05	0.000259	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—NR3C1—systemic lupus erythematosus	1.59e-05	0.000259	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.59e-05	0.000259	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PPARG—systemic lupus erythematosus	1.58e-05	0.000257	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PPARG—systemic lupus erythematosus	1.58e-05	0.000257	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PPARG—systemic lupus erythematosus	1.58e-05	0.000257	CbGpPWpGaD
Tretinoin—Hypersensitivity—Methotrexate—systemic lupus erythematosus	1.58e-05	0.000113	CcSEcCtD
Tretinoin—Asthenia—Methotrexate—systemic lupus erythematosus	1.53e-05	0.00011	CcSEcCtD
Tretinoin—RARA—Gene Expression—NR3C1—systemic lupus erythematosus	1.53e-05	0.000248	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—NR3C1—systemic lupus erythematosus	1.53e-05	0.000248	CbGpPWpGaD
Tretinoin—Nausea—Prednisone—systemic lupus erythematosus	1.52e-05	0.000109	CcSEcCtD
Tretinoin—Pruritus—Methotrexate—systemic lupus erythematosus	1.51e-05	0.000109	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—IL6—systemic lupus erythematosus	1.5e-05	0.000244	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—NAT2—systemic lupus erythematosus	1.49e-05	0.000242	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.47e-05	0.000238	CbGpPWpGaD
Tretinoin—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.46e-05	0.000105	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—ALB—systemic lupus erythematosus	1.42e-05	0.000231	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ALB—systemic lupus erythematosus	1.42e-05	0.000231	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ALB—systemic lupus erythematosus	1.42e-05	0.000231	CbGpPWpGaD
Tretinoin—Dizziness—Methotrexate—systemic lupus erythematosus	1.41e-05	0.000101	CcSEcCtD
Tretinoin—RARG—Gene Expression—PPARG—systemic lupus erythematosus	1.38e-05	0.000223	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.37e-05	0.000222	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—NOS3—systemic lupus erythematosus	1.36e-05	0.000221	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—NOS3—systemic lupus erythematosus	1.36e-05	0.000221	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—NOS3—systemic lupus erythematosus	1.36e-05	0.000221	CbGpPWpGaD
Tretinoin—Vomiting—Methotrexate—systemic lupus erythematosus	1.36e-05	9.75e-05	CcSEcCtD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.36e-05	0.00022	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—NAT2—systemic lupus erythematosus	1.35e-05	0.00022	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	1.35e-05	0.00022	CbGpPWpGaD
Tretinoin—Rash—Methotrexate—systemic lupus erythematosus	1.35e-05	9.67e-05	CcSEcCtD
Tretinoin—Dermatitis—Methotrexate—systemic lupus erythematosus	1.35e-05	9.66e-05	CcSEcCtD
Tretinoin—Headache—Methotrexate—systemic lupus erythematosus	1.34e-05	9.61e-05	CcSEcCtD
Tretinoin—CYP1A1—PPARA activates gene expression—EP300—systemic lupus erythematosus	1.31e-05	0.000213	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	1.28e-05	0.000208	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.28e-05	0.000208	CbGpPWpGaD
Tretinoin—Nausea—Methotrexate—systemic lupus erythematosus	1.27e-05	9.11e-05	CcSEcCtD
Tretinoin—RXRG—Gene Expression—PPARG—systemic lupus erythematosus	1.26e-05	0.000204	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PTGS2—systemic lupus erythematosus	1.25e-05	0.000202	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PTGS2—systemic lupus erythematosus	1.25e-05	0.000202	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PTGS2—systemic lupus erythematosus	1.25e-05	0.000202	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—PPARG—systemic lupus erythematosus	1.23e-05	0.0002	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—TGFB1—systemic lupus erythematosus	1.22e-05	0.000198	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.22e-05	0.000198	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—PPARG—systemic lupus erythematosus	1.21e-05	0.000196	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—PPARG—systemic lupus erythematosus	1.18e-05	0.000192	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—PPARG—systemic lupus erythematosus	1.18e-05	0.000192	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—JUNB—systemic lupus erythematosus	1.11e-05	0.000181	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	1.09e-05	0.000177	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.08e-05	0.000175	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.07e-05	0.000173	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TYK2—systemic lupus erythematosus	1.06e-05	0.000171	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—EP300—systemic lupus erythematosus	1.04e-05	0.000168	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—EP300—systemic lupus erythematosus	1.04e-05	0.000168	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—EP300—systemic lupus erythematosus	1.04e-05	0.000168	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NAT2—systemic lupus erythematosus	9.93e-06	0.000161	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.68e-06	0.000157	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—RXRA—systemic lupus erythematosus	9.58e-06	0.000155	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.21e-06	0.000149	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NAT2—systemic lupus erythematosus	9.1e-06	0.000148	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.88e-06	0.000144	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	8.85e-06	0.000144	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—VDR—systemic lupus erythematosus	8.85e-06	0.000144	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.53e-06	0.000138	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.47e-06	0.000137	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—RXRA—systemic lupus erythematosus	8.37e-06	0.000136	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MMP9—systemic lupus erythematosus	8.32e-06	0.000135	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—NR3C1—systemic lupus erythematosus	7.96e-06	0.000129	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—EP300—systemic lupus erythematosus	7.89e-06	0.000128	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.82e-06	0.000127	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—VEGFA—systemic lupus erythematosus	7.47e-06	0.000121	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NAT2—systemic lupus erythematosus	7.34e-06	0.000119	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	7.18e-06	0.000116	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.04e-06	0.000114	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TGFB1—systemic lupus erythematosus	6.86e-06	0.000111	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NAT2—systemic lupus erythematosus	6.78e-06	0.00011	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TNF—systemic lupus erythematosus	6.4e-06	0.000104	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.37e-06	0.000103	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	6.21e-06	0.000101	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PPARG—systemic lupus erythematosus	6.17e-06	0.0001	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PPARG—systemic lupus erythematosus	6.05e-06	9.81e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—RXRA—systemic lupus erythematosus	5.56e-06	9.03e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ALB—systemic lupus erythematosus	5.44e-06	8.82e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.39e-06	8.74e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPARG—systemic lupus erythematosus	5.28e-06	8.58e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—NOS3—systemic lupus erythematosus	5.2e-06	8.44e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—IL6—systemic lupus erythematosus	5.17e-06	8.39e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—RXRA—systemic lupus erythematosus	5.1e-06	8.28e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	5.06e-06	8.21e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.94e-06	8.02e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.84e-06	7.86e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPARG—systemic lupus erythematosus	4.8e-06	7.78e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—systemic lupus erythematosus	4.76e-06	7.72e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ALB—systemic lupus erythematosus	4.75e-06	7.71e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—NOS3—systemic lupus erythematosus	4.55e-06	7.38e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.44e-06	7.21e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ALB—systemic lupus erythematosus	4.31e-06	7e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.24e-06	6.88e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—systemic lupus erythematosus	4.16e-06	6.75e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—NOS3—systemic lupus erythematosus	4.12e-06	6.69e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—RXRA—systemic lupus erythematosus	4.12e-06	6.68e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	4.02e-06	6.53e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.02e-06	6.52e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—EP300—systemic lupus erythematosus	3.96e-06	6.42e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.89e-06	6.31e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	3.8e-06	6.17e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—systemic lupus erythematosus	3.77e-06	6.12e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.61e-06	5.87e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.52e-06	5.72e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARG—systemic lupus erythematosus	3.51e-06	5.7e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	3.48e-06	5.65e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—EP300—systemic lupus erythematosus	3.46e-06	5.61e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	3.34e-06	5.41e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.23e-06	5.24e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARG—systemic lupus erythematosus	3.22e-06	5.23e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.16e-06	5.13e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—systemic lupus erythematosus	3.16e-06	5.13e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—EP300—systemic lupus erythematosus	3.14e-06	5.09e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NOS3—systemic lupus erythematosus	3.02e-06	4.9e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—systemic lupus erythematosus	2.9e-06	4.7e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	2.84e-06	4.6e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NOS3—systemic lupus erythematosus	2.77e-06	4.5e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—systemic lupus erythematosus	2.76e-06	4.49e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.63e-06	4.27e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARG—systemic lupus erythematosus	2.6e-06	4.22e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	2.54e-06	4.12e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—systemic lupus erythematosus	2.53e-06	4.11e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	2.4e-06	3.89e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—systemic lupus erythematosus	2.34e-06	3.79e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—EP300—systemic lupus erythematosus	2.3e-06	3.73e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	2.28e-06	3.71e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NOS3—systemic lupus erythematosus	2.23e-06	3.63e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	2.2e-06	3.57e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	2.18e-06	3.55e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	2.16e-06	3.5e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—EP300—systemic lupus erythematosus	2.11e-06	3.42e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	2.06e-06	3.35e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—systemic lupus erythematosus	2.04e-06	3.32e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	2e-06	3.24e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	1.98e-06	3.21e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	1.89e-06	3.07e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	1.89e-06	3.06e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.87e-06	3.04e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	1.79e-06	2.91e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	1.73e-06	2.81e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—EP300—systemic lupus erythematosus	1.7e-06	2.76e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	1.66e-06	2.7e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.61e-06	2.61e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	1.57e-06	2.55e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1.54e-06	2.5e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	1.44e-06	2.34e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	1.41e-06	2.29e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.18e-06	1.92e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.17e-06	1.9e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.06e-06	1.72e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.02e-06	1.65e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	9.29e-07	1.51e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	7.72e-07	1.25e-05	CbGpPWpGaD
